Given that insulin has been shown to inhibit platelet function also through a rapid increase in NO-mediated cGMP and cAMP [84] and platelets are targets of insulin action, in conditions of insulin-resistance such as central obesity, type 2 diabetes, hypertension, the inhibitory actions of insulin on platelets are impaired [85]. Here, INS is linked to Abdominal obesity.